Daraxonrasib Approved for Metastatic Pancreatic Cancer
Key Points FDA approved daraxonrasib (RASONQUE) on August 26, 2026, for adults with metastatic pancreatic adenocarcinoma after at least one
Read MoreKey Points FDA approved daraxonrasib (RASONQUE) on August 26, 2026, for adults with metastatic pancreatic adenocarcinoma after at least one
Read MoreKey Takeaways Autophagy modulation is emerging as a promising strategy to overcome cisplatin-resistant gastric cancer. Researchers identified several existing drugs
Read MoreKey Takeaways Researchers identified how obesity actively promotes leukemia progression through chronic inflammation. High IL-17A levels and reduced GLP-1 signaling
Read MoreKey Points A joint research team from the University of Osaka and MIT discovered how two motor proteins, KIF18A and
Read MoreCancer remains one of the leading causes of morbidity and mortality worldwide. One of the critical challenges in effective cancer
Read MoreOn October 11, 2024, a new research paper was released in Oncotarget’s Volume 15, entitled “Relationship between the expressions of
Read MoreProtein Guard Mechanism – Researchers discovered a defense mechanism for a protein that kills bacteria in infected cells. The University
Read More